Please use this identifier to cite or link to this item: http://ahro.austin.org.au/austinjspui/handle/1/11226
Title: Changes in growth factor levels after thermal ablation in a murine model of colorectal liver metastases.
Authors: Fifis, Theodora;Malcontenti-Wilson, Caterina;Amijoyo, Jason;Anggono, Beatrice;Muralidharan, Vijayaragavan;Nikfarjam, Mehrdad;Christophi, Christopher
Affiliation: Department of Surgery, University of Melbourne, Austin Hospital, Heidelberg, Vic, Australia. tfifis@unimelb.edu.au
Issue Date: 2-Mar-2011
Citation: Hpb : the Official Journal of the International Hepato Pancreato Biliary Association 2011; 13(4): 246-55
Abstract: This study examines changes in the expression of growth factors following thermal ablation (TA) of selected colorectal cancer (CRC) liver metastases.Using mice with established CRC liver metastases, two tumours in each animal were thermally ablated. Liver and tumour tissues were collected at various time-points (days 0, 1, 2, 3, 5 and 7) following TA treatment from the ablation site and from sites distant from ablated tumour. Changes in growth factor expression (epidermal growth factor [EGF], vascular endothelial growth factor [VEGF], hepatocyte growth factor [HGF] and transforming growth factor-β[TGF-β]) in comparison with baseline levels (non-ablated) were assessed by enzyme-linked immunosorbent assay (ELISA) and immunohistochemistry.Baseline TGF-β and VEGF levels in the liver parenchyma of tumour-bearing mice were significantly higher than levels in naive liver parenchyma. Levels of VEGF and HGF decreased after TA treatment in all tissues. Levels of EGF decreased in ablated and distant tumour tissues, but displayed a tendency to increase in liver tissue. Levels of TGF-β also decreased during the first 2 days following TA, but later increased in liver and tumour tissues distant from the ablation site to a level that reached significance in tumour tissue at day 7 (P < 0.001). Decreases in growth factor levels were also observed in animals that underwent laparotomy without TA treatment, which indicates that these decreases were caused by the experimental procedure.Tumour induces upregulation of TGF-β and VEGF in liver parenchyma. Growth factors decreased after TA, but this appears to be the result of the experimental procedure rather than the TA itself. However, TA resulted in increased levels of TGF-β, which may contribute to tumour recurrence.
Internal ID Number: 21418130
URI: http://ahro.austin.org.au/austinjspui/handle/1/11226
DOI: 10.1111/j.1477-2574.2010.00278.x
URL: http://www.ncbi.nlm.nih.gov/pubmed/21418130
Type: Journal Article
Subjects: Animals
Cell Line, Tumor
Colorectal Neoplasms.pathology
Enzyme-Linked Immunosorbent Assay
Epidermal Growth Factor.metabolism
Hepatocyte Growth Factor.metabolism
Immunohistochemistry
Intercellular Signaling Peptides and Proteins.metabolism
Laser Therapy
Liver Neoplasms.metabolism.secondary.surgery
Male
Mice
Mice, Inbred CBA
Time Factors
Transforming Growth Factor beta.metabolism
Vascular Endothelial Growth Factor A.metabolism
Appears in Collections:Journal articles

Files in This Item:
There are no files associated with this item.


Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.